| Product Code: ETC9977909 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Temporal Arteritis Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Temporal Arteritis Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Temporal Arteritis Market - Industry Life Cycle |
3.4 United States (US) Temporal Arteritis Market - Porter's Five Forces |
3.5 United States (US) Temporal Arteritis Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 United States (US) Temporal Arteritis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 United States (US) Temporal Arteritis Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 United States (US) Temporal Arteritis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Temporal Arteritis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of temporal arteritis in the aging population |
4.2.2 Growing awareness and diagnosis of temporal arteritis among healthcare professionals |
4.2.3 Technological advancements in diagnostic tools and treatment options for temporal arteritis |
4.3 Market Restraints |
4.3.1 Limited availability of effective treatments for temporal arteritis |
4.3.2 High cost associated with the diagnosis and treatment of temporal arteritis |
4.3.3 Lack of specific guidelines for the management of temporal arteritis |
5 United States (US) Temporal Arteritis Market Trends |
6 United States (US) Temporal Arteritis Market, By Types |
6.1 United States (US) Temporal Arteritis Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Temporal Arteritis Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 United States (US) Temporal Arteritis Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.1.4 United States (US) Temporal Arteritis Market Revenues & Volume, By Aristocort, 2021- 2031F |
6.1.5 United States (US) Temporal Arteritis Market Revenues & Volume, By Bubbli-Pred, 2021- 2031F |
6.1.6 United States (US) Temporal Arteritis Market Revenues & Volume, By Immunosuppressive Agents, 2021- 2031F |
6.1.7 United States (US) Temporal Arteritis Market Revenues & Volume, By Adalimumab, 2021- 2031F |
6.1.8 United States (US) Temporal Arteritis Market Revenues & Volume, By Infliximab, 2021- 2031F |
6.2 United States (US) Temporal Arteritis Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Temporal Arteritis Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 United States (US) Temporal Arteritis Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3 United States (US) Temporal Arteritis Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Temporal Arteritis Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 United States (US) Temporal Arteritis Market Revenues & Volume, By Homecare, 2021- 2031F |
6.3.4 United States (US) Temporal Arteritis Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.3.5 United States (US) Temporal Arteritis Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) Temporal Arteritis Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Temporal Arteritis Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 United States (US) Temporal Arteritis Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.4.4 United States (US) Temporal Arteritis Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 United States (US) Temporal Arteritis Market Import-Export Trade Statistics |
7.1 United States (US) Temporal Arteritis Market Export to Major Countries |
7.2 United States (US) Temporal Arteritis Market Imports from Major Countries |
8 United States (US) Temporal Arteritis Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis of temporal arteritis |
8.2 Number of clinical trials for new treatments or diagnostic tools for temporal arteritis |
8.3 Patient satisfaction with the quality of care received for temporal arteritis. |
9 United States (US) Temporal Arteritis Market - Opportunity Assessment |
9.1 United States (US) Temporal Arteritis Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 United States (US) Temporal Arteritis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 United States (US) Temporal Arteritis Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 United States (US) Temporal Arteritis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Temporal Arteritis Market - Competitive Landscape |
10.1 United States (US) Temporal Arteritis Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Temporal Arteritis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here